Xenon Pharmaceuticals Inc(NASDAQ:XENE) 
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment...
Website: http://www.xenon-pharma.com
Founded: 1996
Full Time Employees: 100
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 29.71
H 30.76
L 29.20
C 29.40
V 728,349
10EMA 29.40
20EMA 29.40
60EMA 29.40
120EMA 29.40
250EMA 29.40